Trial watch: Radioimmunotherapy for oncological indications

Keyphrases

• Oncologic 100%
• Radiation Therapy 100%
• Radioimmunotherapy 100%
• Antineoplastic 100%
• Immunotherapeutics 50%
• Cancer Cells 50%
• Clinical Trials 50%
• Recent Advances 50%
• Radiotherapy 50%
• Chemotherapy 50%
• In Cancer 50%
• Treatment Modalities 50%
• Apoptosis 50%
• Cancer Patients 50%
• Transformed Cells 50%
• Immunostimulatory 50%
• Radiation Effects 50%
• Tumor-specific Immune Response 50%
• Immunogenic Cell Death 50%
• Anticancer Immune Response 50%
• Abscopal Effect 50%
• Proliferative Arrest 50%
• Cell-extrinsic 50%
• Out-of-field 50%
• Damage-associated Molecular Patterns 50%
• Extrinsic Mechanism 50%

Medicine and Dentistry

• Radioimmunotherapy 100%
• Radiation Therapy 100%
• Immune Response 66%
• Anticarcinogen 66%
• Malignant Neoplasm 33%
• Cancer Cell 33%
• Clinical Trial 33%
• Specific Tumor 33%
• Programmed Cell Death 33%
• Immunomodulating Agent 33%
• Immunogenic Cell Death 33%
• Transformed Cell 33%
• Abscopal Effect 33%
• Treatment Modality 33%
• Chemotherapy 33%